The Human Medicines Regulations 2012 are the UK law the MHRA cites when it discusses peptides. Law firm Culbert Ellis gives the starting point: "Peptides are not, as a category, illegal in the UK."

What do the Human Medicines Regulations 2012 call a medicine?

Regulation 2 gives two tests. A substance is a medicinal product if it is presented for disease prevention or treatment in people. It also qualifies if it "may be used by or administered to human beings" with a view to modifying a physiological function or making a diagnosis.

What do the Human Medicines Regulations 2012 prohibit?

Regulation 46 says: the sale, supply or offer of an unauthorised medicinal product is restricted by that provision. Regulation 284 bars any advertisement "likely to lead to the use of a prescription only medicine".

How does the MHRA apply this to peptides?

Case by case. Its official Lynda Scammell said: research-only wording does not decide classification when the presentation indicates a medicinal purpose.

This is a summary of the Human Medicines Regulations 2012, not legal advice. See how they apply to peptide clinics and to BPC-157.

Scope for European readers

This is a dated account of the research or policy described in the linked sources. The stated jurisdiction, study product and population matter. A US or UK announcement does not establish authorisation or availability across Europe. Nothing in this report establishes results for an EPS catalogue material. Read the research-use statement for the storefront's scope.